Evaluation of 143 Cases of Immune Thrombocytopenic Purpura With Regards to Clinical Course and Response to Treatment | Zendy

Murat Albayrak | Zendy; Özlem Şahin Balçık | Zendy; Şahika Zeynep Akı | Zendy; Ayla Gökmen | Zendy; Funda Ceran | Zendy; Osman Yokuş | Zendy; Simten Dağdaş | Zendy; Meltem Aylı | Zendy; Gülsüm Özet | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Evaluation of 143 Cases of Immune Thrombocytopenic Purpura With Regards to Clinical Course and Response to Treatment

Author(s) -

Murat Albayrak,

Özlem Şahin Balçık,

Şahika Zeynep Akı,

Ayla Gökmen,

Funda Ceran,

Osman Yokuş,

Simten Dağdaş,

Meltem Aylı,

Gülsüm Özet

Publication year - 2010

Publication title -

eurasian journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.337

H-Index - 13

eISSN - 1308-8742

pISSN - 1308-8734

DOI - 10.5152/eajm.2010.34

Subject(s) - medicine , danazol , thrombocytopenic purpura , splenectomy , thrombopoietin , prednisolone , gastroenterology , platelet , corticosteroid , azathioprine , rituximab , surgery , spleen , lymphoma , endometriosis , stem cell , disease , haematopoiesis , biology , genetics

Immune thrombocytopenic purpura (ITP) is also known as idiopathic thrombocytopenic purpura. Increased platelet destruction and insufficient platelet production are both responsible for its etiopathogenesis. ITP can be diagnosed after excluding other possible causes of thrombocytopenia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research